Apremilast Impurity HS093313, with the CAS number 2077897-93-7, is a chemical compound associated with the pharmaceutical drug apremilast, which is primarily used in the treatment of autoimmune conditions such as psoriasis and psoriatic arthritis. As an impurity, HS093313 may arise during the synthesis or formulation of apremilast and is typically characterized by its molecular structure, which may include specific functional groups that influence its chemical behavior and stability. Impurities like HS093313 are often assessed for their potential impact on the efficacy and safety of the final pharmaceutical product. The characterization of such impurities usually involves techniques like high-performance liquid chromatography (HPLC), mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, concentration, and potential effects. Regulatory agencies require thorough analysis of impurities to ensure that they remain within acceptable limits to maintain the quality and safety of the drug.

Apremilast Impurity HS093313

2077897-93-7: Apremilast Impurity HS093313, with the CAS number 2077897-93-7, is a chemical compound associated with the pharmaceutical drug apremilast, which is primarily used in the treatment of autoimmune conditions such as psoriasis and psoriatic arthritis. As an impurity, HS093313 may arise during the synthesis or formulation of apremilast and is typically characterized by its molecular structure, which may include specific functional groups that influence its chemical behavior and stability. Impurities like HS093313 are often assessed for their potential impact on the efficacy and safety of the final pharmaceutical product. The characterization of such impurities usually involves techniques like high-performance liquid chromatography (HPLC), mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, concentration, and potential effects. Regulatory agencies require thorough analysis of impurities to ensure that they remain within acceptable limits to maintain the quality and safety of the drug.

CAS 2077897-93-7

Apremilast Impurity HS093313

Apremilast Impurity 22

Ref: ST-EA-CP-A77038